SR9009 (Stenabolic) 20mg/ml

SR9009 (Stenabolic) 20mg/ml

AUD$149.00

Clinical research has shown that SR9009 may have the ability to;

✔ Increase endurance and reduce recovery time.
✔ Burn fat by increasing glucose uptake in skeletal muscle tissue.
✔ Increase resting metabolic rate.
✔ Reduce inflammation and prevent oxidative damage to blood vessels.

BULK PRICING
1 2-4 5-9 10-19 20+
$149.00 $145.28 $141.55 $134.10 $119.20
Return or exchange your unopened product within 30 days. The highest quality SARMS in Australia. Returns can be sent to our Australian warehouse. Our checkout is SSL encrypted and completely secure. We will ship the same day that your order is processed, quick and fast. Our products are verified by independent third party laboratories to meet quality standards. All product batches and lots are assigned unique identifiers so there is always traceability.
Category:
000

CAS

1379686-30-2

Molar Mass

437.94 g/mol

Chemical Formula

C20H24ClN3O4S

IUPAC Name

ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate

Synonyms

SHRED, Sr9009, SR-9009, SR 9009, Stenabolic

Storage

Room temperature

Country of Origin

USA

Standard

20mg/mL ±10%

Terms of sale

This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Information presented is based upon evidence found in clinical studies. Research products sold on this site are not bound by the ‘Therapeutic Goods Act of 1989’. Please familiarise yourself with our Terms & Conditions prior to ordering.

Although Stenabolic SR9009 is usually grouped into the category of SARMS, it is actually a PPAR modulator. It works by activating AMP-activated protein kinase and stimulating glucose uptake in skeletal muscle tissue. Stenabolic (SR9009) has been studied for its ability to reverse metabolic disorders and was considered as a treatment for obesity. It was shown to be very successful in this regard.
When used in clinical trials, Stenabolic (SR9009) was shown to increase the subjects resting metabolic rate, while positively influencing lipid and glucose metabolism in the liver.

SR 9009 was also shown to impact the reaction of macrophages. Macrophages are cells that eliminate dead and dying cells from the body during inflammation

Dosage:
Studies of Stenabolic (SR9009) suggest dosages can be approximately  10mg, twice per day – due to a shorter half life.

Studies and additional info:
https://newatlas.com/scripps-drug-sr9009-exercise-mimic/28651/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343186/
https://www.ncbi.nlm.nih.gov/pubmed/25536025
https://www.ncbi.nlm.nih.gov/pubmed/22460951